{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:23:16Z","timestamp":1780410196106,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ygyno.2025.10.008","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:55:21Z","timestamp":1760730921000},"page":"154-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prognostic value of positive peritoneal cytology in FIGO 2009 stage IA grade 1 endometrioid endometrial cancer"],"prefix":"10.1016","volume":"202","author":[{"given":"Christian","family":"Dagher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier","family":"Selenica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten F.J.","family":"Bakhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Iasonos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora H.","family":"Ellenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Momeni-Boroujeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Mario M.","family":"Leitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Weigelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2025.10.008_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/jjco\/hyad140","volume":"54","author":"Shigeta","year":"2024","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.10.008_bb0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3802\/jgo.2014.25.1.30","article-title":"FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype","volume":"25","author":"Haltia","year":"2014","journal-title":"J. Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.10.008_bb0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2012.09.026","article-title":"Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer","volume":"128","author":"Garg","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.10.008_bb0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41598-021-03975-5","article-title":"Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer","volume":"12","author":"Kanno","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ygyno.2025.10.008_bb0025","article-title":"The impact of positive peritoneal cytology on the survival rates of early-stage-disease endometrial cancer patients: systematic review and meta-analysis","volume":"60","author":"Pergialiotis","year":"2024","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.008_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2019.100514","article-title":"The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas","volume":"44","author":"Wang","year":"2020","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.ygyno.2025.10.008_bb0035","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann. Stat."},{"key":"10.1016\/j.ygyno.2025.10.008_bb0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2023.05.059","article-title":"Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma","volume":"174","author":"Rios-Doria","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2025.10.008_bb0045","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2025.10.008_bb0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ygyno.2025.05.015","article-title":"Prognostic significance of estrogen receptor expression and estrogen signaling in endometrial carcinomas of no specific molecular profile: a comprehensive molecular and pathologic analysis","volume":"198","author":"Lam","year":"2025","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.008_bb0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjc.6600698","article-title":"Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus","volume":"88","author":"Kasamatsu","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2025.10.008_bb0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/jjco\/hyw063","article-title":"Influence of positive peritoneal cytology on prognostic factors and survival in early-stage endometrial cancer: a systematic review and meta-analysis","volume":"46","author":"Lee","year":"2016","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2025.10.008_bb0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2023.06.578","article-title":"Prognostic significance of positive peritoneal cytology in endometrial carcinoma based on ESGO\/ESTRO\/ESP risk classification: a multicenter retrospective study","volume":"176","author":"Zhang","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2025.10.008_bb0070","first-page":"903","article-title":"Effects of preoperative diagnostic hysteroscopy on peritoneal cytology and prognosis in patients with non-endometrioid carcinoma","volume":"58","author":"Zhai","year":"2023","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"4","key":"10.1016\/j.ygyno.2025.10.008_bb0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/joc.joc_53_22","article-title":"Association of peritoneal cytology with other prognostic factors in endometrial cancer","volume":"39","author":"Maricic","year":"2022","journal-title":"J. Cytol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.10.008_bb0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2020.07.010","article-title":"Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer","volume":"159","author":"Matsuo","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2025.10.008_bb0085","article-title":"Rewinding the clock on positive peritoneal cytology in endometrial cancer: does it predict prognosis in low-risk disease?","volume":"35","author":"Fumagalli","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2025.10.008_bb0090","first-page":"435","article-title":"Intrauterine manipulator use and malignant peritoneal cytology risk in laparoscopic hysterectomy for endometrial cancer","volume":"28","author":"Yoshida","year":"2021","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"13","key":"10.1016\/j.ygyno.2025.10.008_bb0095","doi-asserted-by":"crossref","first-page":"8320","DOI":"10.1245\/s10434-022-12356-9","volume":"29","author":"Siegenthaler","year":"2022","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2025.10.008_bb0100","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1136\/ijgc-2021-002445","article-title":"Impact of surgical approach on prevalence of positive peritoneal cytology and lymph-vascular invasion in patients with early-stage endometrial carcinoma: a National Cancer Database study","volume":"31","author":"Nasioudis","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2025.10.008_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1515\/raon-2016-0035","article-title":"Incidence of positive peritoneal cytology in patients with endometrial carcinoma after hysteroscopy vs. dilatation and curettage","volume":"51","author":"Dovnik","year":"2017","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.ygyno.2025.10.008_bb0110","first-page":"108","article-title":"Hysteroscopy and peritoneal cytology in endometrial cancer: a meta-analysis","volume":"251","author":"Chang","year":"2020","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2025.10.008_bb0115","first-page":"2011","article-title":"Safety of hysteroscopy for diagnosing endometrial cancer: a systematic review and meta-analysis","volume":"46","author":"Du","year":"2020","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"2","key":"10.1016\/j.ygyno.2025.10.008_bb0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine neoplasms, version 1.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.ygyno.2025.10.008_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.881850","article-title":"Association of tumor size with myometrial invasion, lymphovascular space invasion, lymph node metastasis, and recurrence in endometrial cancer: a meta-analysis of 40 studies with 53,276 patients","volume":"12","author":"Jin","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ygyno.2025.10.008_bb0130","first-page":"1262","article-title":"Positive peritoneal cytology and oncologic outcomes in low- and intermediate-risk endometrial cancer","volume":"27","author":"Scott","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2025.10.008_bb0135","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.humpath.2015.06.015","article-title":"Risk factor analysis of recurrence in low-grade endometrial adenocarcinoma","volume":"46","author":"Roma","year":"2015","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.10.008_bb0140","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/ijgc-2023-005149","article-title":"Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion","volume":"34","author":"Jamieson","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"11","key":"10.1016\/j.ygyno.2025.10.008_bb0145","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/1878-0261.13193","article-title":"ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma","volume":"16","author":"Megino-Luque","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ygyno.2025.10.008_bb0150","article-title":"Phase Ib study of the histone deacetylase 6 inhibitor Citarinostat in combination with paclitaxel in patients with advanced solid tumors","volume":"11","author":"Gordon","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ygyno.2025.10.008_bb0155","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2307\/2532836","article-title":"Resampling procedures to compare two survival distributions in the presence of right censored data","volume":"52","author":"Heller","year":"1996","journal-title":"Biometrics"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825010248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825010248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:38:57Z","timestamp":1780407537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825010248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":31,"alternative-id":["S0090825825010248"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.10.008","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of positive peritoneal cytology in FIGO 2009 stage IA grade 1 endometrioid endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}